Irinotel 100mg Injection contains irinotecan, a prescription chemotherapy medicine used primarily as part of treatment for advanced or metastatic colorectal cancer. It belongs to the topoisomerase I inhibitor class and works by interfering with an enzyme that cancer cells need to replicate and grow. Because chemotherapy requires individualized dosing and monitoring, a qualified oncology professional must administer this medicine and determine whether it suits the patient’s treatment plan.

Irinotecan is an established component of colorectal cancer treatment and may be used alone or together with other chemotherapy medicines, depending on the patient’s diagnosis, previous treatment, overall health, and oncology protocol. The 100 mg/5 mL presentation contains irinotecan at a concentration of 20 mg/mL. Official prescribing information identifies irinotecan injection as an intravenous medicine that requires dilution before administration.

How Irinotel 100mg Injection Works

The active ingredient, irinotecan, inhibits topoisomerase I, an enzyme involved in DNA replication. Cancer cells divide rapidly and depend heavily on DNA replication. By interfering with this process, irinotecan causes DNA damage that can prevent cancer cells from continuing to multiply and may lead to their death.

This medicine does not provide an instant cure for cancer. Instead, doctors use it as one component of a carefully planned cancer-treatment regimen. Your oncologist may combine it with medicines such as fluorouracil and folinic acid or other agents when clinically appropriate. The exact regimen depends on the cancer type, stage, prior therapy, and individual patient factors.

Uses of Irinotel 100mg Injection

Doctors commonly prescribe this medicine for advanced or metastatic colorectal cancer. In appropriate patients, irinotecan can form part of first-line combination treatment or treatment after previous therapy has failed or the cancer has progressed.

Your oncologist will consider several factors before prescribing treatment. These may include blood-cell counts, liver function, performance status, previous chemotherapy, other medicines, and the patient’s ability to tolerate treatment. Never use this injection simply because you believe your symptoms indicate cancer. A cancer specialist must establish the diagnosis and treatment plan.

How Irinotel 100mg Injection Is Given

A healthcare professional administers this medicine through an intravenous infusion. Patients should never attempt to inject or prepare it themselves. The product information specifies that irinotecan injection must be diluted before intravenous administration.

The oncologist determines the dose and schedule according to the treatment regimen. Some patients receive irinotecan as part of combination chemotherapy, while others may receive it under different protocols. Your medical team may also prescribe medicines to help control nausea or certain infusion-related symptoms.

Do not change the dose, skip scheduled treatment, or receive an additional dose without your oncology team’s instructions.

Important Side Effects and Safety Information

Irinotecan carries important safety warnings, particularly regarding diarrhea and myelosuppression. Early diarrhea can occur during or shortly after infusion and may occur with cholinergic symptoms such as abdominal cramping, sweating, increased salivation, or other symptoms. Late diarrhea can occur more than 24 hours after treatment and may become serious or life-threatening if not treated promptly.

Severe reduction in blood-cell counts can also occur. Neutropenia can increase the risk of serious infection. Your healthcare team will therefore monitor blood counts and may adjust, delay, or interrupt treatment when necessary. Fever during chemotherapy requires prompt medical attention because infection can become serious when white blood-cell counts are low.

Other possible adverse effects can include nausea, vomiting, weakness, abdominal discomfort, decreased appetite, hair loss, and other chemotherapy-related effects. The severity varies between patients. Report new or worsening symptoms promptly rather than waiting for the next appointment.

Who Should Tell the Doctor Before Treatment?

Tell your oncology team about every prescription medicine, over-the-counter medicine, vitamin, and supplement you use. Certain medicines can alter irinotecan exposure and potentially affect safety. The prescribing information also highlights the importance of considering UGT1A1 activity because reduced UGT1A1 activity can increase the risk of severe neutropenia.

Inform your doctor if you have liver problems, previous severe reactions to chemotherapy, low blood-cell counts, or other significant medical conditions. Tell your healthcare provider if you are pregnant, planning pregnancy, or breastfeeding. Current labeling advises against breastfeeding during irinotecan treatment and for at least seven days after the final dose.

Storage and Handling

Irinotel 100mg Injection is a cytotoxic prescription medicine and requires appropriate professional handling. Product-specific storage requirements should always be checked against the manufacturer’s current packaging and prescribing information. Some irinotecan 100 mg/5 mL products specify controlled room-temperature storage, while exact requirements can vary by manufacturer.

Do not use a vial if the packaging is damaged, leaking, or otherwise compromised. Healthcare professionals should follow appropriate cytotoxic-drug handling procedures.

Why Choose Irinotel 100mg Injection?

For patients whose oncologists have selected irinotecan therapy, this medicine provides an established chemotherapy option for colorectal cancer treatment. Its clinical role comes from its ability to interfere with cancer-cell DNA replication, making it an important component of several colorectal cancer treatment regimens.

However, the value of treatment depends on correct diagnosis, appropriate regimen selection, professional administration, laboratory monitoring, and prompt management of adverse reactions. Always purchase and use prescription chemotherapy medicines through a legitimate, appropriately licensed pharmacy and only against a valid prescription.

Order Irinotel 100mg Injection Safely

If your oncologist has specifically prescribed Irinotel 100mg Injection, confirm the strength, formulation, manufacturer, quantity, and prescription requirements before ordering. Because this is a prescription chemotherapy medicine, it should be supplied through an authorized pharmacy and administered by qualified healthcare professionals. Do not purchase an alternative strength or substitute without your oncology team’s approval.

Frequently Asked Questions

1. What is Irinotel 100mg Injection used for?

It contains irinotecan and is primarily used as part of chemotherapy treatment for advanced or metastatic colorectal cancer.

2. Does Irinotel 100mg Injection cure cancer?

It should not be described as a standalone cure. Irinotecan is a chemotherapy medicine used within specific cancer-treatment regimens. The expected benefit depends on the cancer type, stage, treatment combination, and individual response.

3. How is Irinotel 100mg Injection administered?

A trained healthcare professional administers irinotecan by intravenous infusion after appropriate preparation and dilution.

4. What is the most important side effect to watch for?

Severe diarrhea is one of the most important risks. Late diarrhea can become life-threatening, so patients should follow their oncology team’s instructions and seek prompt medical advice for significant or persistent diarrhea.

5. Can Irinotel 100mg Injection lower blood-cell counts?

Yes. Irinotecan can cause myelosuppression, including neutropenia. Doctors monitor blood counts throughout treatment and may modify therapy when necessary.